2026 Annual Congress: Hematologic Malignancies
Hosted by National Comprehensive Cancer Network
- 18 – 19 September 2026
- New York Marriott Marquis, New York, United States of America
- Clinical MedicineHaematology, Oncology & Cancer Research
Let others know you'll be there. This does not register you for the event.
Registration
Event has endedRegistration is handled by the organiser
Key facts
2026 Annual Congress: Hematologic Malignancies is a congress held 18 – 19 September 2026 in New York Marriott Marquis, New York, United States of America, organised by National Comprehensive Cancer Network.
- Dates:
- 18 – 19 September 2026
- Format:
- Hybrid (in person and online)
- Venue:
- New York Marriott Marquis, New York, United States of America
- Subjects:
- Haematology, Oncology & Cancer Research
- Organiser:
- National Comprehensive Cancer Network
- Official website:
- nccn.org/hem
The Annual Congress: Hematologic Malignancies, organized by the National Comprehensive Cancer Network, is designed for the entire oncology team to explore treatment options and supportive care for various hematologic malignancies. Chaired by Andrew D. Zelenetz, MD, PhD, the event takes place in New York, New York, with virtual attendance options also available. It offers continuing education credits for physicians, PAs, nurses, pharmacists, and other oncology professionals.
Topics
- Advances in Leukemia Care
- Evolving Lymphoma Treatment Landscape
- Innovations in Cellular and Immune Therapies
- Treatment-Related Toxicity Monitoring and Management
- Plasma Cell Neoplasms
- Myeloid and Rare Hematologic Neoplasms
- Supportive Care and Survivorship
- Interprofessional Collaboration and Care
Who should attend
Designed for the Entire Oncology Team, including physicians, PAs, nurses, pharmacists, and other oncology professionals.
Organising Committee
Chair: Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center.
Programme highlights
View full programmeSpeakers
View all 26 speakersJohns Hopkins Kimmel Cancer Center
Collaborative Strategies for Optimizing Small-Volume Drug DeliveryVanderbilt-Ingram Cancer Center
Managing Toxicities of Bispecific Antibodies and CAR T-Cell Therapies in the Outpatient SettingMemorial Sloan Kettering Cancer Center
Managing Toxicities of Bispecific Antibodies and CAR T-Cell Therapies in the Outpatient SettingThe UChicago Medicine Comprehensive Cancer Center
Optimizing Treatment for Relapsed/Refractory Follicular LymphomaMass General Cancer Institute
Managing Toxicities of Outpatient Oral Therapies for Chronic Myeloid LeukemiaMayo Clinic Comprehensive Cancer Center
Evolving Treatment Strategies in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma and Closing Remarks
Organiser and contact
Host organisation
National Comprehensive Cancer NetworkContact
- Email:
- [email protected]
Advertisement
Related events
- Mayo Clinic Radiation Oncology: Current Practice and Future DirectionLahaina, United States of America11–15 Jan 2027
- AACR Annual Meeting 2027Orlando, United States of America2–7 Apr 2027
- ASCO Annual Meeting 2027Chicago, United States of America4–8 Jun 2027
- 23rd Meeting of the European Association for Haematopathology (EA4HP-SH 2026)Berlin, Germany3–8 Oct 2026
- The 2nd Brighton Tumour Microenvironment ConferenceBrighton, United Kingdom12–13 Oct 2026
- EACR Conference: Chromosomes in Crisis – From Chromosomal Instability to Catastrophes in Cancer GenomesBerlin, Germany3–5 Nov 2026